Cargando…

1653 Results of a Treatment Protocol Encouraging First-Line Use of Fidaxomicin for Select Patients with Clostridium difficile Infection (CDI)

Detalles Bibliográficos
Autores principales:	Navalkele, Bhagyashri, Downham, Gemma, Haynes, Kevin, Gallagher, Jason, Reilly, Joseph, Trivedi, Manish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782296/ http://dx.doi.org/10.1093/ofid/ofu052.1199

Ejemplares similares

467 Analysis of Clinical and Economical Outcomes of Fidaxomicin Use for Clostridium difficile infections
por: Flaherty, Sarah, et al.
Publicado: (2014)

527 Age-Related Changes in the Incidence of Community-Associated Clostridium Difficile Infection (CDI)
por: Faden, Howard
Publicado: (2014)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

1635 A Retrospective Study Comparing Outcomes of Present on Admission Clostridium difficile Infection (CDI) vs Non-present on Admission CDI at a Tertiary-care Hospital in Detroit
por: Awali, Reda A., et al.
Publicado: (2014)

453 Association of Clostridium difficile Infection (CDI) with Excess Mortality after Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA)
por: Ramanan, Poornima, et al.
Publicado: (2014)

1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014)

1636 Low Incidence Of Clostridium Difficile Infection (CDI) in Patients Treated with Community Outpatient Parenteral Antimicrobial Therapy (CoPAT)
por: Wong, Ken Koon, et al.
Publicado: (2014)

1627 Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
por: Lloyd, Aaron, et al.
Publicado: (2014)

114 Case Mix Index Predicts Healthcare Facility Onset Clostridium difficile Infection (CDI) Reported to the National Healthcare Safety Network (NHSN)
por: Thompson, Nicola D., et al.
Publicado: (2014)

902 Hospital Characteristics and Infection Prevention and Control Strategies Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI) in Canadian Hospitals
por: Williams, Victoria, et al.
Publicado: (2014)

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI
por: Navalkele, Bhagyashri D., et al.
Publicado: (2016)

115 Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI)
por: Phipps, Erin C., et al.
Publicado: (2014)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

71 Alterations in the Gut Microbiome in Recurrent Clostridium difficile Infection
por: Wang, Gary, et al.
Publicado: (2014)

1628 Accuracy of Healthcare Facility-Onset Clostridium difficile Classification
por: Trappler, Regan, et al.
Publicado: (2014)

1634 Clinical Characteristics of Relapses AND Reinfections in Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2014)

1626 The relationship of Bristol Stool Scale to Clostridium difficile infection
por: Caroff, Daniel, et al.
Publicado: (2014)

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
por: Watt, Maureen, et al.
Publicado: (2016)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

1649 Acquisition of Clostridium difficile Associated with Potentially Contaminated Inpatient Rooms
por: Williams, Catherine, et al.
Publicado: (2014)

1673 Microbial and Inflammatory Markers for Fatal Clostridium difficile Associated Diarrhea
por: Jiang, Zhi-Dong, et al.
Publicado: (2014)

1620 Extraintestinal Clostridium difficile infections: A Single Center Experience
por: Gupta, Arjun, et al.
Publicado: (2014)

1644 Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Crews, Jonathan, et al.
Publicado: (2014)

1660 Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
por: Reddy, Sujan C., et al.
Publicado: (2014)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

1798 Oral, Frozen Fecal Microbiota Capsules for Relapsing Clostridium difficile Infection
por: Youngster, Ilan, et al.
Publicado: (2014)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1623 Ertapenem is Associated with an Increased Risk of Clostridium difficile Infections Among Surgical Patients
por: Lee, Seungwon, et al.
Publicado: (2014)

1629 The Incidence of Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis in the United States
por: Deshpande, Abhishek, et al.
Publicado: (2014)

1633 The Importance of Considering Different Healthcare Settings When Estimating the Incidence of Clostridium difficile
por: Kuntz, Jennifer, et al.
Publicado: (2014)

1632 Preventon of Clostridium Difficile Infection: A Human Factors and Systems Engineering Approach
por: Yanke, Eric, et al.
Publicado: (2014)

1643 Clostridium difficile Infection Related Emergency Department Visits in the United States 2006-2009
por: Deshpande, Abhishek, et al.
Publicado: (2014)

1622 Statin Use and Hospital-onset Clostridium difficile Infection; A Case Control Study
por: Elashery, Ahmad Ramy
Publicado: (2014)

1647 Are Hospital Floors an Underappreciated Reservoir for Transmission of Clostridium difficile and Methicillin-Resistant Staphylococcus aureus?
por: Deshpande, Abhishek, et al.
Publicado: (2014)

438 Genetic Variants Associated with the Development of Clostridium Difficile Infection during Autologous Stemcell Transplantation
por: Apewokin, Senu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l24r4rf1o3i00uuskqdc55jvfk